BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33545115)

  • 1. Discovery of small molecule positive allosteric modulators of the secretin receptor.
    Dengler DG; Harikumar KG; Pollari S; Sun Q; Brown BT; Shinoki-Iwaya A; Ardecky R; Miller LJ; Sergienko EA
    Biochem Pharmacol; 2021 Mar; 185():114451. PubMed ID: 33545115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Testing Funnel for Identification of Small-Molecule Modulators Targeting Secretin Receptors.
    Dengler DG; Sun Q; Holleran J; Pollari S; Beutel J; Brown BT; Shinoki Iwaya A; Ardecky R; Harikumar KG; Miller LJ; Sergienko EA
    SLAS Discov; 2021 Jan; 26(1):1-16. PubMed ID: 32749201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Duplexed High-Throughput Screen to Identify Allosteric Modulators of the Glucagon-Like Peptide 1 and Glucagon Receptors.
    Morris LC; Days EL; Turney M; Mi D; Lindsley CW; Weaver CD; Niswender KD
    J Biomol Screen; 2014 Jul; 19(6):847-58. PubMed ID: 24525870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and pharmacology of the covalent GLP-1 receptor (GLP-1R) allosteric modulator BETP: A novel tool to probe GLP-1R pharmacology.
    Willard FS; Ho JD; Sloop KW
    Adv Pharmacol; 2020; 88():173-191. PubMed ID: 32416867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational development of a high-affinity secretin receptor antagonist.
    Dong M; Harikumar KG; Raval SR; Milburn JE; Clark C; Alcala-Torano R; Mobarec JC; Reynolds CA; Ghirlanda G; Christopoulos A; Wootten D; Sexton PM; Miller LJ
    Biochem Pharmacol; 2020 Jul; 177():113929. PubMed ID: 32217097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secretin occupies a single protomer of the homodimeric secretin receptor complex: insights from photoaffinity labeling studies using dual sites of covalent attachment.
    Dong M; Lam PC; Pinon DI; Orry A; Sexton PM; Abagyan R; Miller LJ
    J Biol Chem; 2010 Mar; 285(13):9919-9931. PubMed ID: 20100828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potential positive allosteric modulator of glucagon-like peptide 1 receptor through virtual screening and experimental study.
    Redij T; Ma J; Li Z; Hua X; Li Z
    J Comput Aided Mol Des; 2019 Nov; 33(11):973-981. PubMed ID: 31758355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and Function of Cross-class Complexes of G Protein-coupled Secretin and Angiotensin 1a Receptors.
    Harikumar KG; Augustine ML; Lee LT; Chow BK; Miller LJ
    J Biol Chem; 2016 Aug; 291(33):17332-44. PubMed ID: 27330080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Cysteine Trapping to Map Spatial Approximations between Residues Contributing to the Helix N-capping Motif of Secretin and Distinct Residues within Each of the Extracellular Loops of Its Receptor.
    Dong M; Lam PC; Orry A; Sexton PM; Christopoulos A; Abagyan R; Miller LJ
    J Biol Chem; 2016 Mar; 291(10):5172-84. PubMed ID: 26740626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorescence resonance energy transfer analysis of secretin docking to its receptor: mapping distances between residues distributed throughout the ligand pharmacophore and distinct receptor residues.
    Harikumar KG; Lam PC; Dong M; Sexton PM; Abagyan R; Miller LJ
    J Biol Chem; 2007 Nov; 282(45):32834-43. PubMed ID: 17827151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening.
    Zhou Q; Guo W; Dai A; Cai X; Vass M; de Graaf C; Shui W; Zhao S; Yang D; Wang MW
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34201418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor.
    Harikumar KG; Simms J; Christopoulos G; Sexton PM; Miller LJ
    Biochemistry; 2009 Dec; 48(49):11773-85. PubMed ID: 19886671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactam constraints provide insights into the receptor-bound conformation of secretin and stabilize a receptor antagonist.
    Dong M; Te JA; Xu X; Wang J; Pinon DI; Storjohann L; Bordner AJ; Miller LJ
    Biochemistry; 2011 Sep; 50(38):8181-92. PubMed ID: 21851058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allosteric modulation of endogenous metabolites as an avenue for drug discovery.
    Wootten D; Savage EE; Valant C; May LT; Sloop KW; Ficorilli J; Showalter AD; Willard FS; Christopoulos A; Sexton PM
    Mol Pharmacol; 2012 Aug; 82(2):281-90. PubMed ID: 22576254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric Optical Control of a Class B G-Protein-Coupled Receptor.
    Broichhagen J; Johnston NR; von Ohlen Y; Meyer-Berg H; Jones BJ; Bloom SR; Rutter GA; Trauner D; Hodson DJ
    Angew Chem Int Ed Engl; 2016 May; 55(19):5865-8. PubMed ID: 27059784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial approximation between secretin residue five and the third extracellular loop of its receptor provides new insight into the molecular basis of natural agonist binding.
    Dong M; Lam PC; Pinon DI; Sexton PM; Abagyan R; Miller LJ
    Mol Pharmacol; 2008 Aug; 74(2):413-22. PubMed ID: 18467541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of the innate electrophilicity of 4-(3-(benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine (BETP), a small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor.
    Eng H; Sharma R; McDonald TS; Edmonds DJ; Fortin JP; Li X; Stevens BD; Griffith DA; Limberakis C; Nolte WM; Price DA; Jackson M; Kalgutkar AS
    Drug Metab Dispos; 2013 Aug; 41(8):1470-9. PubMed ID: 23653442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of secretin docking to its intact receptor using multiple photolabile probes distributed throughout the pharmacophore.
    Dong M; Lam PC; Pinon DI; Hosohata K; Orry A; Sexton PM; Abagyan R; Miller LJ
    J Biol Chem; 2011 Jul; 286(27):23888-99. PubMed ID: 21566140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.